Rosemont is extremely pleased to announce the launch of our Art Competition in conjunction with University of Leeds this March, which offers all students an opportunity to design artwork for Rosemont’s brand new Innovation Centre.
On December 1st Rosemont Pharmaceuticals received Marketing Authorisation for Glycopyrronium Bromide 1mg/5ml Oral Solution. This prescription only medicinal product is indicated for symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders. Sialorrhoea, or chronic pathological drooling, is the unintentional loss of saliva from the mouth and is most commonly caused by neuromuscular conditions.
Rosemont Pharmaceuticals has completed the acquisition of Essential Pharma Liquids Limited from Essential Pharmaceuticals Limited.
The Lloyds Bank British Business Excellence Awards (BBEA) celebrates and showcases the resilience, innovation and creativity of British businesses.
Sales growth of 49% since June ’20, with significant investment secured to support future business ambitions
We are overjoyed, humbled and proud to have won ‘Product Launch of The Year’ in the Pharmacy Product of the Year Awards 2021! A fantastic achievement by all
#communitypharmacy #pharmacy #awards #pharmaceuticals
New Chief Commercial Officer, Eric Vick, and Chief Financial Officer, Tim Busby.
We're delighted to be shortlisted as finalists in the 'Effectiveness - Brand Campaign' category at the PM Society Awards 2021! A great achievement recognising the work of our teams involved
#awards #pharmaceuticals #pharmaceuticalindustry